Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain

Journal of Neuroscience Research

Volumn 89, Issue 10, 2011, Pages 1646-1657

  Dagyte, Girstaute ^a   Luiten, Paul G ^a   De Jager, Tim ^a   Gabriel, Cecilia ^b   Mocaër, Elisabeth ^b   Den Boer, Johan A ^a   Van der Zee, Eddy A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Affective disorders; Chronic footshock stress; Depression; Synaptic plasticity

Indexed keywords

AGOMELATINE; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; FOOTSHOCK; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SYNAPTIC TRANSMISSION; THALAMUS LATERAL NUCLEUS; THALAMUS POSTERIOR NUCLEUS;

ACETAMIDES; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; MALE; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SYNAPSINS;

EID: 79961208900     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22697     Document Type: Article

References (71)

1. Alfarez DN, Joels M, Krugers HJ. 2003. Chronic unpredictable stress impairs long-term potentiation in rat hippocampal CA1 area and dentate gyrus in vitro. Eur J Neurosci 17: 1928-1934.
2. Alfonso J, Frick LR, Silberman DM, Palumbo ML, Genaro AM, Frasch AC. 2006. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 59: 244-251.
3. 2 receptors. Naunyn Schmiedebergs Arch Pharmacol 367: 553-561.
4. Banasr M, Soumier A, Hery M, Mocaer E, Daszuta A. 2006. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 59: 1087-1096.
5. Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, Drago F, Racagni G, Popoli M. 2007. Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology 32: 2511-2519.
6. Bessa JM, Ferreira D, Melo I, Marques F, Cerqueira JJ, Palha JA, Almeida OF, Sousa N. 2009. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling. Mol Psychiatry 14: 764-773, 739.
7. Castren E, Voikar V, Rantamaki T. 2007. Role of neurotrophic factors in depression. Curr Opin Pharmacol 7: 18-21.
8. Cerqueira JJ, Mailliet F, Almeida OF, Jay TM, Sousa N. 2007. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci 27: 2781-2787.
9. Cesca F, Baldelli P, Valtorta F, Benfenati F. 2010. The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91: 313-348.
10. Chi P, Greengard P, Ryan TA. 2001. Synapsin dispersion and reclustering during synaptic activity. Nat Neurosci 4: 1187-1193.
11. 2C receptor protein in the rat CNS. Neuropharmacology 39: 123-132.
12. Conboy L, Tanrikut C, Zoladz PR, Campbell AM, Park CR, Gabriel C, Mocaer E, Sandi C, Diamond DM. 2009. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats. Int J Neuropsychopharmacol 12: 329-341.
13. Dagyte G, Van der Zee EA, Postema F, Luiten PG, Den Boer JA, Trentani A, Meerlo P. 2009. Chronic but not acute foot-shock stress leads to temporary suppression of cell proliferation in rat hippocampus. Neuroscience 162: 904-913.
14. Dagyte G, Trentani A, Postema F, Luiten PG, Den Boer JA, Gabriel C, Mocaer E, Meerlo P, Van der Zee EA. 2010. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats. CNS Neurosci Ther 16: 195-207.
15. Dagyte G, Crescente I, Postema F, Seguin L, Gabriel C, Mocaer E, Boer JA, Koolhaas JM. 2011a. Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress. Behav Brain Res 218: 121-128.
16. Dagyte G, Den Boer JA, Trentani A. 2011b. The cholinergic system and depression. Behav Brain Res 221: 574-582.
17. de Bodinat C, Guardiola-Lemaitre B, Mocaer E, Renard P, Munoz C, Millan MJ. 2010. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 9: 628-642.
18. De Camilli P, Harris SMJr, Huttner WB, Greengard P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J Cell Biol 96: 1355-1373.
19. Duman RS. 2004. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol Med 5: 11-25.
20. Ferreira A, Rapoport M. 2002. The synapsins: beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59: 589-595.
21. Ferreira A, Kao HT, Feng J, Rapoport M, Greengard P. 2000. Synapsin III: developmental expression, subcellular localization, and role in axon formation. J Neurosci 20: 3736-3744.
22. Fuchs E, Flugge G, Ohl F, Lucassen P, Vollmann-Honsdorf GK, Michaelis T. 2001. Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus. Physiol Behav 73: 285-291.
23. Gao Y, Bezchlibnyk YB, Sun X, Wang JF, McEwen BS, Young LT. 2006. Effects of restraint stress on the expression of proteins involved in synaptic vesicle exocytosis in the hippocampus. Neuroscience 141: 1139-1148.
24. Goldwater DS, Pavlides C, Hunter RG, Bloss EB, Hof PR, McEwen BS, Morrison JH. 2009. Structural and functional alterations to rat medial prefrontal cortex following chronic restraint stress and recovery. Neuroscience 164: 798-808.
25. Goodwin GM, Emsley R, Rembry S, Rouillon F. 2009. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 70: 1128-1137.
26. Greengard P, Valtorta F, Czernik AJ, Benfenati F. 1993. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259: 780-785.
27. Gronli J, Bramham C, Murison R, Kanhema T, Fiske E, Bjorvatn B, Ursin R, Portas CM. 2006. Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper. Pharmacol Biochem Behav 85: 842-849.
28. Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, Greengard P. 1999. Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354: 269-279.
29. Huttner WB, Schiebler W, Greengard P, De Camilli P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96: 1374-1388.
30. Iwata M, Shirayama Y, Ishida H, Kawahara R. 2006. Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats. Neuroscience 141: 1301-1313.
31. Joca SR, Ferreira FR, Guimaraes FS. 2007. Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems. Stress 10: 227-249.
32. Joels M. 2006. Corticosteroid effects in the brain: U-shape it. Trends Pharmacol Sci 27: 244-250.
33. Joels M, Krugers HJ, Lucassen PJ, Karst H. 2009. Corticosteroid effects on cellular physiology of limbic cells. Brain Res 1293: 91-100.
34. Kendler KS, Karkowski LM, Prescott CA. 1999. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156: 837-841.
35. Kennedy SH, Emsley R. 2006. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol 16: 93-100.
36. Kuipers SD, Trentani A, Den Boer JA, Ter Horst GJ. 2003. Molecular correlates of impaired prefrontal plasticity in response to chronic stress. J Neurochem 85: 1312-1323.
37. Kuipers SD, Trentani A, Westenbroek C, Bramham CR, Korf J, Kema IP, Ter Horst GJ, Den Boer JA. 2006. Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment. Neuropharmacology 50: 428-440.
38. Lei Y, Tejani-Butt SM. 2010. N-methyl-D-aspartic acid receptors are altered by stress and alcohol in Wistar-Kyoto rat brain. Neuroscience 169: 125-131.
39. Magarinos AM, McEwen BS. 1995. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 69: 83-88.
40. McEwen BS. 2007. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87: 873-904.
41. McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E. 2010. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry 15: 237-249.
42. Millan MJ. 2009. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics 6: 53-77.
43. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D. 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306: 954-964.
44. 2C receptor blockade. Psychopharmacology 177: 448-458.
45. Moghaddam B. 1993. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 60: 1650-1657.
46. Muller HK, Wegener G, Popoli M, Elfving B. 2011. Differential expression of synaptic proteins after chronic restraint stress in rat prefrontal cortex and hippocampus. Brain Res 1385: 26-37.
47. Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, Bonifacino T, Mallei A, Baldelli P, Racagni G, Raiteri M, Benfenati F, Bonanno G, Popoli M. 2010. Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One 5: e8566.
48. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34: 13-25.
49. 2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 10: 661-673.
50. Oomen CA, Soeters H, Audureau N, Vermunt L, van Hasselt FN, Manders EM, Joels M, Lucassen PJ, Krugers H. 2010. Severe early life stress hampers spatial learning and neurogenesis, but improves hippocampal synaptic plasticity and emotional learning under high-stress conditions in adulthood. J Neurosci 30: 6635-6645.
51. Paizanis E, Renoir T, Lelievre V, Saurini F, Melfort M, Gabriel C, Barden N, Mocaer E, Hamon M, Lanfumey L. 2010. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared with fluoxetine in glucocorticoid receptor-impaired mice. Int J Neuropsychopharmacol 13: 759-774.
52. Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Maestroni GJ, Zisapel N, Cardinali DP. 2008. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 85: 335-353.
53. Papp M, Gruca P, Boyer PA, Mocaer E. 2003. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28: 694-703.
54. Pavlides C, Nivon LG, McEwen BS. 2002. Effects of chronic stress on hippocampal long-term potentiation. Hippocampus 12: 245-257.
55. Paxinos G, Watson C. 2007. The rat brain in stereotaxic coordinates, 6th ed. San Diego: Academic Press.
56. Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, McEwen BS, Morrison JH. 2004. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125: 1-6.
57. Rapp S, Baader M, Hu M, Jennen-Steinmetz C, Henn FA, Thome J. 2004. Differential regulation of synaptic vesicle proteins by antidepressant drugs. Pharmacogenomics J 4: 110-113.
58. Rasmusson AM, Shi L, Duman R. 2002. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology 27: 133-142.
59. Sairanen M, O'Leary OF, Knuuttila JE, Castren E. 2007. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Neuroscience 144: 368-374.
60. Silva R, Mesquita AR, Bessa J, Sousa JC, Sotiropoulos I, Leao P, Almeida OF, Sousa N. 2008. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta. Neuroscience 152: 656-669.
61. Soumier A, Banasr M, Lortet S, Masmejean F, Bernard N, Kerkerian-Le-Goff L, Gabriel C, Millan MJ, Mocaer E, Daszuta A. 2009. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology 34: 2390-2403.
62. Sudhof TC, Czernik AJ, Kao HT, Takei K, Johnston PA, Horiuchi A, Kanazir SD, Wagner MA, Perin MS, De Camilli P, et al. 1989. Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science 245: 1474-1480.
63. Tordera RM, Garcia-Garcia AL, Elizalde N, Segura V, Aso E, Venzala E, Ramirez MJ, Del Rio J. 2011. Chronic stress and impaired glutamate function elicit a depressive-like phenotype and common changes in gene expression in the mouse frontal cortex. Eur Neuropsychopharmacol 21: 23-32.
64. Trentani A, Kuipers SD, Ter Horst GJ, Den Boer JA. 2002. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: implications for stress-related cortical pathology? Eur J Neurosci 15: 1681-1691.
65. Trentani A, Kuipers SD, te Meerman GJ, Beekman J, ter Horst GJ, den Boer JA. 2003. Immunohistochemical changes induced by repeated footshock stress: revelations of gender-based differences. Neurobiol Dis 14: 602-618.
66. Weaver DR, Rivkees SA, Reppert SM. 1989. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci 9: 2581-2590.
67. Westenbroek C, Ter Horst GJ, Roos MH, Kuipers SD, Trentani A, den Boer JA. 2003. Gender-specific effects of social housing in rats after chronic mild stress exposure. Prog Neuropsychopharmacol Biol Psychiatry 27: 21-30.
68. Westenbroek C, Den Boer JA, Veenhuis M, Ter Horst GJ. 2004. Chronic stress and social housing differentially affect neurogenesis in male and female rats. Brain Res Bull 64: 303-308.
69. Westenbroek C, Snijders TA, den Boer JA, Gerrits M, Fokkema DS, Ter Horst GJ. 2005. Pair-housing of male and female rats during chronic stress exposure results in gender-specific behavioral responses. Horm Behav 47: 620-628.
70. Witter MP, Naber PA, van Haeften T, Machielsen WC, Rombouts SA, Barkhof F, Scheltens P, Lopes da Silva FH. 2000. Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus 10: 398-410.
71. Wu LM, Han H, Wang QN, Hou HL, Tong H, Yan XB, Zhou JN. 2007. Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression. Neuropsychopharmacology 32: 2500-2510.